Breaking News
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
October 15, 2018 - Half of parents say young children are afraid of doctor’s visits
October 15, 2018 - Study shows how fingerprint-based drug screening works on the living and deceased
October 15, 2018 - Study reveals potential to monitor progression of Alzheimer’s disease by measuring brain antioxidant levels
October 15, 2018 - FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
October 15, 2018 - Promising new therapeutic approach against Ebola virus identified
October 15, 2018 - Study unravels how cancer stem cells use normal genes in abnormal ways
October 15, 2018 - Healthcare systems fail to deliver at affordable prices finds report
October 15, 2018 - Intensive BP Therapy in Diabetes May Lower Risk for CV Events
October 15, 2018 - Muscle relaxants increase risk of respiratory complications
October 15, 2018 - Female birds become more promiscuous after hatchings fail in the first breeding attempt
October 15, 2018 - Humans occupied Madagascar thousands of years later than previously thought
October 15, 2018 - Is Kidney Dialysis Always Needed When Septic Shock Strikes?
October 15, 2018 - Study shows invasive lung cancer surgery can lead to long-term opioid use
October 15, 2018 - Sugar, a “sweet” tool to understand brain injuries
October 14, 2018 - King’s commemorates activities and research on World Arthritis Day
October 14, 2018 - Humana and VFW NY team up on Stop 22 initiative to increase awareness of veterans committing suicide
October 14, 2018 - Water fluoridation contributes to urinary fluoride levels in pregnant women in Canada
October 14, 2018 - Study of children in Romanian orphanages tells cautionary tale about family separation
October 14, 2018 - Previous Endologix AFX Safety Notice classified by FDA as Class I recall
October 14, 2018 - Legal scholars sound alarm on academies’ report about returning research results to participants
October 14, 2018 - UNIST selects six extraordinary scholars to be induced as ‘Rising-star Distinguished Professor’
October 14, 2018 - Scientists find new way to help asthmatics breathe more easily
October 14, 2018 - New ‘gag rule’ may adversely impact health care of pregnant women
October 14, 2018 - Rosacea – Genetics Home Reference
October 14, 2018 - When the fighting crosses the line
October 14, 2018 - New findings could benefit patients with triple-negative breast cancer
October 14, 2018 - UK Biobank provides wealth of information for further genetic studies
October 14, 2018 - KHN’s ‘What the Health?’ Falling premiums and rising political tensions
October 14, 2018 - Duvelisib Promising for Chronic Lymphocytic Leukemia, SLL
October 14, 2018 - Tailored drug cocktails offer hope to kids with aggressive brain tumors
October 14, 2018 - Common gene variants linked to migraine risk in African-American children
October 14, 2018 - Funding requests are being accepted by BlueCross BlueShield of Tennessee Community Trust
October 14, 2018 - Using pulsed electric fields in cancer therapy
October 14, 2018 - Major Childbirth Complications More Likely for Black Women
October 14, 2018 - Young cancer survivors at greater risk of mental health disorders
October 14, 2018 - Common herbicide compound could help fight hospital-acquired fungal infections
October 14, 2018 - Alterations in genes encoding proteins contribute to ADHD development
October 14, 2018 - New patient-centric website launched in Europe to empower people with chronic conditions
October 14, 2018 - Antimicrobial signaling molecule has lower activity against hepatitis C virus in most humans
October 14, 2018 - Genomic dark matter activity connects Parkinson’s and psychiatric diseases
October 14, 2018 - Cornell dots equipped with antibody fragments offer a new cancer weapon
October 14, 2018 - Addressing social and cultural factors is key to reducing burden of type 2 diabetes
October 14, 2018 - Study reveals why females age more slowly than males
October 14, 2018 - DNA vaccine shown to provide long-term protection from Ebola
October 14, 2018 - Gene therapy shown to remove core component of Parkinson’s disease
October 14, 2018 - Obamacare premiums dip for first time. Some call it a correction
October 14, 2018 - Scientists use haploid stem cells to produce mice with same-sex parents
October 14, 2018 - New transgenic mouse model sheds light on biological causes of Parkinson’s disease
October 14, 2018 - Halobetasol Propionate Lotion Shows Efficacy for Tx of Psoriasis
October 14, 2018 - Overweight pregnant women can safely cut calories, restrict weight gain
October 14, 2018 - Scientists find new way to predict obesity-related disease risk
October 14, 2018 - Lab Innovations to host new range of laboratory product launches in Birmingham
Smuggling RNA into cells can activate the immune system to fight cancer

Smuggling RNA into cells can activate the immune system to fight cancer

image_pdfDownload PDFimage_print

Training the body’s immune cells to seek out and fight cancer is a promising new approach in the fight against the disease. That’s because immune cells are already generally equipped to distinguish between healthy and infected or diseased cells. But in many cases, the cancers themselves have evolved ways to either dampen or evade the normal immune response.

The idea of a “cancer vaccine” to amp up the immune system to overcome these tactics is appealing but difficult to implement. But recently immunologist and oncologist Ronald Levy, MD, joined forces with chemists Paul Wender, PhD, and Robert Waymouth, PhD, to learn whether introducing bits of genetic code called mRNAs into a special class of immune cells could do the trick.

The researchers published their results last week in the Proceedings of the National Academies of Science.

Typically, researchers wishing to activate an immune response — whether it be for a standard run-of-the-mill vaccination or even cancer immunotherapy — focus on delivering a protein specific to the virus or cell to which they want to trigger an attack. The immune system recognizes the foreign protein and ramps up its response to the perceived threat. In contrast, mRNA molecules provide protein-making instructions to a cell, rather than the protein itself. This approach has one main advantage.

As Wender explained to me in a recent email:

mRNAs can be used to code for the synthesis of almost any protein and that message can be catalytically expressed, or used repeatedly, by a cell to make many copies of the protein.

That is, once in a cell one mRNA molecule can trigger the production of multiple copies of a given protein, intensifying and prolonging the immune response.

The type of cell the researchers targeted in their study is called an antigen-presenting cell, or APC. APCs serve as a kind of bulletin board in an old West post office, displaying cancer proteins like “wanted” posters. Passing immune cells then take note and ready themselves to attack and kill the rogue cancer cells throughout  the body. Wender, Levy and Waymouth wondered whether they could introduce mRNAs into the antigen-presenting cells that encoded cancer-specific proteins, or antigens, of their choice.

The concept is easier explained than done, however. As my colleague Taylor Kubota elegantly explained in earlier news coverage, mRNAs are negatively charged, while the cell membrane is positively charged. This makes it extremely difficult to transport mRNA molecules through the cell membrane and into the cell.

Waymouth and Wender came up with a transport system they’ve termed CART (for charge-altering releasable transporters) that enfolds the mRNA and ferries it across the membrane. Once inside, the transporters naturally degrade into neutral small molecules, releasing the mRNA to be recognized and translated by the cell’s protein-making machinery.

In the current study, the researchers used the CART system to teach immune cells in mice to recognize and destroy lymphoma cells throughout the animals’ bodies. The approach was uncommonly successful: Eight of ten mice with moderately sized tumors experienced a complete regression of measurable tumors, and 40 percent of mice with larger tumors were cured of their disease.

“I was surprised that the CART treatment was able to cure the animals with already established tumors,” Levy said. In the future, the researchers hope to target real tumor antigens and prove that the system is safe for humans.

Wender added:

Obviously, there is more to be done to move this from animal models to human trials, but the current results are very encouraging and bode well for the future. CARTs provide a robust and general solution to ‘delivery’, which is a, if not the, major obstacle associated with the implementation of many emerging technologies.

Image by Momentmal

Tagged with:

About author

Related Articles